Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00032942
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2002-04-05
Brief Title:
Lofexidine for Opiate Withdrawal - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
A Phase III Placebo-Controlled Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Status:
COMPLETED
Status Verified Date:
2008-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate lofexidine for opiate withdrawal
Detailed Description:
An 11 day inpatient placebo-controlled double-blind study of 96 opiate dependent treatment seeking individuals randomized to 2 medication groups lofexidine and placebo to be conducted in inpatient units at 3 treatment sites
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None